tykhr
sign in
free sign up
Anebulo Pharmaceuticals Inc
Biotechnology
Healthcare
ANEB
25.93 M shares
NASDAQ US
traded
28 Mar 2025
listed
no
open
1.39
52 week high
3.08
high
1.43
52 week low
0.99
low
1.25
growth
-31.31 %
previous Close
1.40
P/E ratio
market cap
42.79 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-2.20 M
-63.02 %
eps
0.00 %
-69.80 %
eps surprise
0.00 %
net profit margin
-220073600.00 %
0.00 %
operating incoming
-2.41 M
-79.96 %
net change in cash
-1.69 M
17.68 %
cash on hand
1.40 M
-54.62 %
cost of revenue
0.00 %
top